# β-alanine Supplementation in Adults With Overweight/Obesity

> **NCT05329610** · NA · COMPLETED · sponsor: **Nottingham Trent University** · enrollment: 30 (actual)

## Conditions studied

- Prediabetes
- Hyperglycemia
- Overweight or Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Beta-alanine
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05329610
- **Lead sponsor:** Nottingham Trent University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-05
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329610, "β-alanine Supplementation in Adults With Overweight/Obesity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05329610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*